Azelnidipine plus olmesartan versus amlodipine plus olmesartan on arterial stiffness and cardiac function in hypertensive patients: a randomized trial [Corrigendum]

This article refers to:

Azelnidipine plus olmesartan versus amlodipine plus olmesartan on arterial stiffness and cardiac function in hypertensive patients: a randomized trial

Takami T, Saito Y. Drug Design, Development and Therapy. 2013;7:175–183.

On page 177, line 26, heading “Measurement of LVMI and LF diastolic function” should have been “Measurement of LVMI and LV diastolic function”. Line 32, “Devereux et al¹⁸” should read “Devereux et al¹⁹”. Line 40, “(E/e’ ratio) were measured as previously described.¹⁹” should read “(E/e’ ratio) were measured as previously described.²⁰”.

On page 181, line 15, “baPWV with LVMI.²⁰” should read “baPWV with LVMI.²¹”. Line 23, “baPWV and LVMI, E/A ratio.²⁰” should read “baPWV and LVMI, E/A ratio.^21,22”. Line 28 “diastolic dysfunction.²¹” should read “diastolic dysfunction.²³”. Line 38 “is high.²²” should read “is high.²⁴”. Line 39, “in clinical treatment.²³” should read “in clinical treatment.²⁵”. Line 57, “A recent cohort study²⁴” should read “A recent cohort study²¹”.

On page 182, line 1, “diastolic heart failure.²⁵” should read “diastolic heart failure.²⁶”. Line 3, “untreated hypertensive patients.²⁶” should read “untreated hypertensive patients.²⁷”. Line 6, “linear regression analysis.²⁷” should read “linear regression analysis.²¹”.

On page 183, the references 18 to 27 should be updated as shown below:

• 18. Takami T. Evaluation of arterial stiffness in morning hypertension under high-dose valsartan compared to valsartan plus low-dose diuretic. Hypertens Res. 2009;32:1086–1090.

• 19. Devereux RB, Palmieri V, Sharpe N, et al. Effects of once-daily angiotensin-converting enzyme inhibition and calcium channel blockade-based antihypertensive treatment regimens on left ventricular hypertrophy and diastolic filling in hypertension: the prospective randomized enalapril study evaluating regression of ventricular enlargement (PRESERVE) trial. Circulation. 2001;104:1248–1254.

• 20. Ito H, Ishii K, Kihara H, et al. Adding thiazide to a renin-angiotensin blocker improves left ventricular relaxation and improves heart failure in patients with hypertension. Hypertens Res. 2012;35:93–99.

• 21. Xu L, Jiang CQ, Lam TH, et al. Arterial stiffness and left-ventricular diastolic dysfunction: Guangzhou Biobank Cohort Study-CVD. J Hum Hypertens. 2011;25:152–158.

• 22. Kim MN, Park SM, Shim WJ, et al. The relationship between aortic stiffness and left ventricular dyssynchrony in hypertensive patients with preserved left ventricular systolic function. Clin Exp Hypertens. 2012;34:410–416.

• 23. Schillaci G, Pasqualini L, Verdecchia P, et al. Prognostic significance of left ventricular diastolic dysfunction in essential hypertension. J Am Coll Cardiol. 2002;39:2005–2011.

• 24. Ommen SR, Nishimura RA, Appleton CP, et al. Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: A comparative simultaneous Doppler-catheterization study. Circulation. 2000;102:1788–1794.

• 25. Hillis GS, Møller JE, Pellikka PA, et al. Noninvasive estimation of left ventricular filling pressure by e/é is a powerful predictor of survival after acute myocardial infarction. J Am Coll Cardiol. 2004;43:360–367.

• 26. Yambe M, Tomiyama H, Hirayama Y, et al. Arterial stiffening as a possible risk factor for both atherosclerosis and diastolic heart failure. Hypertens Res. 2004;27:625–631.

• 27. Jaroch J, Łoboz Grudzień K, Bociąga Z, et al. The relationship of carotid arterial stiffness to left ventricular diastolic dysfunction in untreated hypertension. Kardiol Pol. 2012;70:223–231.